*October 2023*
Sandip P. Patel, MD discusses treatment options available for patients with EGFR-mutant NSCLC who progress on EGFR TKIs and platinum-based chemotherapy.
The EGFR Resisters is a global community of patients and caregivers impacted by EGFR-positive lung cancer. We’re here to share knowledge, offer support and collaborate to drive progress in research and care. We are here to share treatment experiences, information about clinical trials, breaking news about research developments, and other information with each other.